158 related articles for article (PubMed ID: 36373203)
21. SARS-CoV-2 infection among healthcare workers whom already received booster vaccination during epidemic outbreak of omicron variant in Taiwan.
Sheng WH; Chang HC; Chang SY; Hsieh MJ; Chen YC; Wu YY; Pan SC; Wang JT; Chen YC
J Formos Med Assoc; 2023 May; 122(5):376-383. PubMed ID: 36564300
[TBL] [Abstract][Full Text] [Related]
22. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak at a College With High Coronavirus Disease 2019 (COVID-19) Vaccination Coverage-Connecticut, August 2021-September 2021.
Bart SM; Curtiss CC; Earnest R; Lobe-Costonis R; Peterson H; McWilliams C; Billig K; Hadler JL; Grubaugh ND; Arcelus VJ; Sosa LE
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S243-S250. PubMed ID: 35675696
[TBL] [Abstract][Full Text] [Related]
23. Vaccination Hesitancy among Health-Care-Workers in Academic Hospitals Is Associated with a 12-Fold Increase in the Risk of COVID-19 Infection: A Nine-Month Greek Cohort Study.
Ntziora F; Kostaki EG; Grigoropoulos I; Karapanou A; Kliani I; Mylona M; Thomollari A; Tsiodras S; Zaoutis T; Paraskevis D; Sipsas NV; Antoniadou A; Sfikakis PP
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062230
[TBL] [Abstract][Full Text] [Related]
24. Reported Exposures Among In-Person Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in 6 States, September 2020-June 2021.
Free H; Luckhaupt SE; Billock RM; Groenewold MR; Burrer S; Sweeney MH; Wong J; Gibb K; Rodriguez A; Vergara XP; Cummings KJ; Lavender A; Argueta G; Crawford HL; Erukunuakpor K; Karlsson ND; Armenti K; Thomas H; Gaetz K; Dang G; Harduar-Morano L; Modji K
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S216-S224. PubMed ID: 35717638
[TBL] [Abstract][Full Text] [Related]
25. Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System.
Fitzpatrick V; Rivelli A; Blair C; Copeland K; Richards J
Public Health Rep; 2021 May; 136(3):361-367. PubMed ID: 33673779
[TBL] [Abstract][Full Text] [Related]
26. Association between personal protective equipment and SARS-CoV-2 infection risk in emergency department healthcare workers.
Schmitz D; Vos M; Stolmeijer R; Lameijer H; Schönberger T; Gaakeer MI; de Groot B; Eikendal T; Wansink L; Ter Avest E
Eur J Emerg Med; 2021 Jun; 28(3):202-209. PubMed ID: 33105329
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 infection risk among 77,587 healthcare workers: a national observational longitudinal cohort study in Wales, United Kingdom, April to November 2020.
Hollinghurst J; North L; Szakmany T; Pugh R; Davies GA; Sivakumaran S; Jarvis R; Rolles M; Pickrell WO; Akbari A; Davies G; Griffiths R; Lyons J; Torabi F; Fry R; Gravenor MB; Lyons RA
J R Soc Med; 2022 Dec; 115(12):467-478. PubMed ID: 35796183
[TBL] [Abstract][Full Text] [Related]
28. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study.
Kahlert CR; Persi R; Güsewell S; Egger T; Leal-Neto OB; Sumer J; Flury D; Brucher A; Lemmenmeier E; Möller JC; Rieder P; Stocker R; Vuichard-Gysin D; Wiggli B; Albrich WC; Babouee Flury B; Besold U; Fehr J; Kuster SP; McGeer A; Risch L; Schlegel M; Friedl A; Vernazza P; Kohler P
Clin Microbiol Infect; 2021 Sep; 27(9):1336-1344. PubMed ID: 34020033
[TBL] [Abstract][Full Text] [Related]
29. [SARS-CoV-2 infection in occupational settings in Catalonia.].
Biarnés-Martínez M; Fàbregas M; Coma E; Pera G; Fina F; Rivera-Arco A; Guiriguet C; Méndez-Boo L; Medina M
Rev Esp Salud Publica; 2022 May; 96():. PubMed ID: 35506485
[TBL] [Abstract][Full Text] [Related]
30. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff.
Martin CA; Patel P; Goss C; Jenkins DR; Price A; Barton L; Gupta P; Zaccardi F; Jerina H; Duraisingham S; Brunskill NJ; Khunti K; Pareek M
J Public Health (Oxf); 2022 Jun; 44(2):234-245. PubMed ID: 33200200
[TBL] [Abstract][Full Text] [Related]
31. Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals.
Takayama Y; Komatsu T; Wada T; Nihonyanagi S; Hoshiyama T; Moriya T; Shimamura S; Kajigaya N; Naito M; Takeuchi O; Bando Y; Watanabe M; Iwamura M; Hanaki H
J Nippon Med Sch; 2022 Nov; 89(5):513-519. PubMed ID: 35644553
[TBL] [Abstract][Full Text] [Related]
32. Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study.
Howard-Anderson JR; Adams C; Dube WC; Smith TC; Sherman AC; Edupuganti N; Mendez M; Chea N; Magill SS; Espinoza DO; Zhu Y; Phadke VK; Edupuganti S; Steinberg JP; Lopman BA; Jacob JT; Fridkin SK; Collins MH
Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1664-1671. PubMed ID: 35156597
[TBL] [Abstract][Full Text] [Related]
33. National seroepidemiological study of COVID-19 after the initial rollout of vaccines: Before and at the peak of the Omicron-dominant period in Japan.
Arashiro T; Arai S; Kinoshita R; Otani K; Miyamoto S; Yoneoka D; Kamigaki T; Takahashi H; Hibino H; Okuyama M; Hayashi A; Kikuchi F; Morino S; Takanashi S; Wakita T; Tanaka-Taya K; Suzuki T; Suzuki M
Influenza Other Respir Viruses; 2023 Feb; 17(2):e13094. PubMed ID: 36824391
[TBL] [Abstract][Full Text] [Related]
34. Occupation and SARS-CoV-2 infection risk among 108 960 workers during the first pandemic wave in Germany.
Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Deckert A; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
Scand J Work Environ Health; 2022 Sep; 48(6):446-456. PubMed ID: 35670286
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
[TBL] [Abstract][Full Text] [Related]
36. Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.
Plumb ID; Fette LM; Tjaden AH; Feldstein L; Saydah S; Ahmed A; Link-Gelles R; Wierzba TF; Berry AA; Friedman-Klabanoff D; Larsen MP; Runyon MS; Ward LM; Santos RP; Ward J; Weintraub WS; Edelstein S; Uschner D
Vaccine; 2023 Apr; 41(15):2596-2604. PubMed ID: 36932031
[TBL] [Abstract][Full Text] [Related]
37. Healthcare workers highly affected during the COVID-19 epidemic wave in Poland prior to vaccination availability: seroprevalence study.
Rosińska M; Stępień M; Kitowska W; Milczarek M; Juszczyk G; Nowacka Z; Gardel A; Hermann A; Bardoń-Błaszkowska A; Cudnik R; Czubak H; Wolniak-Bińkowska M; Źródłowska IA; Sadkowska-Todys M
Med Pr; 2022 Apr; 73(2):109-123. PubMed ID: 35301511
[TBL] [Abstract][Full Text] [Related]
38. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
Hatfield KM; Baggs J; Wolford H; Fang M; Sattar AA; Montgomery KS; Jin S; Jernigan J; Pilishvili T
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S147-S154. PubMed ID: 35856635
[TBL] [Abstract][Full Text] [Related]
40. Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis.
Chandan S; Khan SR; Deliwala S; Mohan BP; Ramai D; Chandan OC; Facciorusso A
J Med Virol; 2022 Apr; 94(4):1428-1441. PubMed ID: 34783055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
